Progeria: Clinical Trials

3 trials for Progeria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Enrolling by invitation 1
Phase 22Completed 1, Enrolling by invitation 1

Follow Progeria: new trials by email Literature Review of Progeria trials Research Report on Progeria

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Progerinin in Healthy Volunteers
Progerinin, Placebo - Hutchinson-Gilford Progeria Syndrome, Werner Syndrome
Phase 1CompletedPRG Science & Technology Co., Ltd.642020-08-242021-09-22
Umbilical Cord Blood Transfusion in Progeria Syndrome
Umbilical Cord Blood Unit - Hutchinson-Gilford Progeria Syndrome
Phase 1 / Phase 2CompletedBundang CHA Hospital22019-03-052020-11-04
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Everolimus and lonafarnib - Progeria
Phase 1 / Phase 2Enrolling by invitationBoston Children's Hospital802015-12-012026-04-02

Narrower conditions

Werner Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Laminopathies (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Nutritional and Metabolic Diseases (3)  ·  DNA Repair-Deficiency Disorders (1)

Interventions

Everolimus (1)  ·  Sirolimus (1)  ·  lonafarnib (1)

Sponsors

Boston Children's Hospital (1)  ·  Bundang CHA Hospital (1)  ·  PRG Science & Technology Co., Ltd. (1)

Countries

United States (2)  ·  South Korea (1)

Top investigators

Min Young Kim, MD, PhD (1)  ·  Monica Kleinman, M.D. (1)